Pulmonary artery catheter use and in-hospital outcomes in cardiac surgery: a systematic review and meta-analysis.

0 CARDIAC & CARDIOVASCULAR SYSTEMS Interdisciplinary cardiovascular and thoracic surgery Pub Date : 2024-07-03 DOI:10.1093/icvts/ivae129
Lisa Q Rong, Grant Luhmann, Antonino Di Franco, Arnaldo Dimagli, Luke A Perry, Andrew P Martinez, Michelle Demetres, C David Mazer, Rinaldo Bellomo, Mario Gaudino
{"title":"Pulmonary artery catheter use and in-hospital outcomes in cardiac surgery: a systematic review and meta-analysis.","authors":"Lisa Q Rong, Grant Luhmann, Antonino Di Franco, Arnaldo Dimagli, Luke A Perry, Andrew P Martinez, Michelle Demetres, C David Mazer, Rinaldo Bellomo, Mario Gaudino","doi":"10.1093/icvts/ivae129","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To determine the association of intraoperative pulmonary artery catheter (PAC) use with in-hospital outcomes in cardiac surgical patients.</p><p><strong>Methods: </strong>MEDLINE, Embase, and Cochrane Library (Wiley) databases were screened for studies that compared cardiac surgical patients receiving intraoperative PAC with controls and reporting in-hospital mortality. Secondary outcomes included intensive care unit length of stay, cost of hospitalization, fluid volume administered, intubation time, inotropes use, acute kidney injury (AKI), stroke, myocardial infarction (MI), and infections.</p><p><strong>Results: </strong>Seven studies (25 853 patients, 88.6% undergoing coronary artery bypass graft surgery) were included. In-hospital mortality was significantly increased with PAC use [odds ratio (OR) 1.57; 95% confidence interval (CI) 1.12-2.20, P = 0.04]; PAC use was also associated with greater intraoperative inotrope use (OR 2.61; 95% CI 1.54-4.41) and costs [standardized mean difference (SMD) = 0.20; 95% CI 0.16-0.23], longer intensive care unit stay (SMD = 0.29; 95% CI 0.25-0.33), and longer intubation time (SMD = 0.44; 95% CI 0.12-0.76).</p><p><strong>Conclusions: </strong>PAC use is associated with significantly increased odds of in-hospital mortality, but the amount and quality of the available evidence is limited. Prospective randomized trials testing the effect of PAC on the outcomes of cardiac surgical patients are urgently needed.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11254303/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interdisciplinary cardiovascular and thoracic surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/icvts/ivae129","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"0","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To determine the association of intraoperative pulmonary artery catheter (PAC) use with in-hospital outcomes in cardiac surgical patients.

Methods: MEDLINE, Embase, and Cochrane Library (Wiley) databases were screened for studies that compared cardiac surgical patients receiving intraoperative PAC with controls and reporting in-hospital mortality. Secondary outcomes included intensive care unit length of stay, cost of hospitalization, fluid volume administered, intubation time, inotropes use, acute kidney injury (AKI), stroke, myocardial infarction (MI), and infections.

Results: Seven studies (25 853 patients, 88.6% undergoing coronary artery bypass graft surgery) were included. In-hospital mortality was significantly increased with PAC use [odds ratio (OR) 1.57; 95% confidence interval (CI) 1.12-2.20, P = 0.04]; PAC use was also associated with greater intraoperative inotrope use (OR 2.61; 95% CI 1.54-4.41) and costs [standardized mean difference (SMD) = 0.20; 95% CI 0.16-0.23], longer intensive care unit stay (SMD = 0.29; 95% CI 0.25-0.33), and longer intubation time (SMD = 0.44; 95% CI 0.12-0.76).

Conclusions: PAC use is associated with significantly increased odds of in-hospital mortality, but the amount and quality of the available evidence is limited. Prospective randomized trials testing the effect of PAC on the outcomes of cardiac surgical patients are urgently needed.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
心脏手术中肺动脉导管的使用与院内预后:系统综述与元分析》。
目的确定心脏手术患者术中使用肺动脉导管(PAC)与院内预后的关系:筛选了MEDLINE、Embase和Cochrane Library (Wiley)数据库中将接受术中肺动脉导管的心脏外科患者与对照组进行比较并报告院内死亡率的研究。次要结果包括重症监护室(ICU)住院时间、住院费用、输液量、插管时间、肌注药物使用、急性肾损伤(AKI)、中风、心肌梗死(MI)和感染:共纳入七项研究(25853 名患者,88.6% 接受冠状动脉旁路移植手术)。使用 PAC 会明显增加院内死亡率(OR 1.57;95% CI 1.12-2.20,P = 0.04);使用 PAC 还与术中使用更多肌力药物有关(OR 2.61;95% CI 1.54-4.41)和费用(SMD = 0.20;95% CI 0.16-0.23)、更长的 ICU 留观时间(SMD = 0.29;95% CI 0.25-0.33)和更长的插管时间(SMD = 0.44;95% CI 0.12-0.76)相关:结论:使用 PAC 与院内死亡率显著增加有关,但现有证据的数量和质量有限。目前急需进行前瞻性随机试验,检验 PAC 对心脏手术患者预后的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Initial single-institutional experience with salvage surgery for stage IV non-small cell lung cancer. Surgery for acute type A aortic dissection. Long-term outcome after repair of interrupted aortic arch in a single center. The modified heart team protocol facilitated the revascularisation decision-making quality in complex coronary artery disease. Significance of measuring the severity of emphysema, in combination with spirometry, on the risk evaluation of patients undergoing major lung resection for cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1